SCHEMBL30392341

SCHEMBL30392341

COc1ccc(CN(C)c2cc(Nc3cccc(-c4ccc(C(=O)O)cn4)c3)nn3c(C(=O)N[C@@H]4C[C@@H]4F)cnc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 9/20 0.39
▸ HPGDS O60760 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ POLB P06746 1/20 0.34
▸ AURKA O14965 3/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ MCHR1 Q99705 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ SYK P43405 1/20 0.32
▸ FGFR3 P22607 1/20 0.32
▸ KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26099037 1.00 TYK2 (0.39) TYK2HPGDSPDE4DPOLBAURKA
SCHEMBL26098589 1.00 TYK2 (0.39) TYK2HPGDSPDE4DPOLBAURKA
SCHEMBL30392502 1.00 TYK2 (0.39) TYK2HPGDSPDE4DPOLBAURKA
SCHEMBL30392726 0.96 TYK2 (0.40) TYK2HPGDSPDE4DPOLBAURKA
SCHEMBL26102885 0.96 TYK2 (0.40) TYK2HPGDSPDE4DPOLBAURKA
SCHEMBL26098601 0.90 TYK2 (0.40) TYK2PDE4DAURKAMAPT
SCHEMBL30392771 0.89 TYK2 (0.43) TYK2PDE4D
SCHEMBL26098254 0.89 TYK2 (0.43) TYK2PDE4D
SCHEMBL30392536 0.89 TYK2 (0.38) TYK2HPGDSPDE4DAURKAFGFR3
SCHEMBL26097861 0.89 TYK2 (0.38) TYK2HPGDSPDE4DAURKAFGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback